UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000041751
Receipt No. R000047653
Scientific Title Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake
Date of disclosure of the study information 2021/12/18
Last modified on 2021/03/31 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake
Acronym Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake
Scientific Title Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake
Scientific Title:Acronym Research on healthy adult men and women who are tired, diminished in vitality, and dissatisfied with sleep quality in daily life of improvement effect by food intake
Region
Japan

Condition
Condition Healthy adult
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effect of subject food intake for 8 consecutive weeks on the subjective evaluation of fatigue, vitality, and sleep, using placebo as a control.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes POMS2 T-score and OSA-MA at before, 4 and 8 weeks
Key secondary outcomes SF36 at before, 4 and 8 weeks and flulike symptoms score during intake period

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification NO
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 Intake of test food daily intake, for 8 weeks
Interventions/Control_2 Intake of placebo daily intake, for 8 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
64 years-old >=
Gender Male and Female
Key inclusion criteria (1) Men and women between 20 and 64 years of age.
(2) Subjects who feel fatigued and less active
(3) Subjects with poor sleep quality
Key exclusion criteria (1) Subjects who regularly use health foods containing the ingredients involved in the test food
(2) Subjects engaged in actions/drugs or health food use to improve fatigue, stress, or sleep.
(3) Subjects with a disease undergoing treatment or with a disease determined to be in need of treatment.
(4) Subjects who have, have been diagnosed with, or are strongly suspected of having a sleep-related illness.
(5) Subjects with a previous diagnosis of chronic fatigue syndrome
(6) Subjects who are being treated for or have a history of mental illness, or are suspected to be suffering from one.
(7) Seriously ill subjects and subjects with a history of serious illness
(8) Subjects with irregular working days (holidays)
(9) Subjects whose lives will become irregular more than once during the research period due to day/night shift work or night work, or who are engaged in physical labor such as heavy lifting.
(10) Subjects with major life changes planned during the study period.
(11) Subjects who have allergic diseases and are constantly taking therapeutic medication.
(12) Subjects with diarrhea
(13) Subjects with less than 3 bowel movements per week.
(14) Subjects who are pregnant or lactating and who plan to become pregnant or breastfeeding during the study period.
(15) Subjects at risk of developing allergies in connection with the study.
(16) Subjects whose physical measurements, physical examination values, and clinical examination values at the pre-examination are significantly outside the reference range.
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Tomoko
Middle name
Last name To
Organization Kenkoukazoku Co., Ltd.
Division name None
Zip code 892-0848
Address 10-2, Hirano-cho, Kagoshima-shi, Kagoshima, 892-0848, JAPAN
TEL 099-223-5211
Email yasushi.nakasone@kenkoukazoku.co.jp

Public contact
Name of contact person
1st name Yasushi
Middle name
Last name Nakasone
Organization Kenkoukazoku Co., Ltd.
Division name None
Zip code 892-0848
Address 10-2, Hirano-cho, Kagoshima-shi, Kagoshima, 892-0848, JAPAN
TEL 099-223-5211
Homepage URL
Email yasushi.nakasone@kenkoukazoku.co.jp

Sponsor
Institute TTC Co., Ltd
Institute
Department

Funding Source
Organization Kenkoukazoku Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Medical Station Clinic Research Ethics Committee
Address 3-12-8, Takaban, Meguroku, Tokyo
Tel 03-6452-2712
Email t.saito@ttc-smo.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 12 Month 18 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2020 Year 08 Month 20 Day
Date of IRB
2020 Year 08 Month 20 Day
Anticipated trial start date
2020 Year 09 Month 11 Day
Last follow-up date
2020 Year 12 Month 18 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 09 Month 10 Day
Last modified on
2021 Year 03 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047653